Baxter International Inc. BAX
23.37
(0.11)
(0.47%)
as of 25 Sep
- Market cap
- $12.2B
- P/E
- 0.0×
Follow BAX
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Baxter International Inc. (BAX) Net income
Baxter International Inc.'s net income for fiscal 2025 was −$957.0M, compared with −$638.0M in fiscal 2024. Over the twelve months to 30 June 2026 it was −$1.1B. Over the past ten years it has ranged from −$2.4B (fiscal 2022) to $5.0B (fiscal 2016); the current reading is higher than 18% of that period. Baxter International Inc. ranks 55th of 55 Medical Instruments & Supplies companies by net income.
Net income, annual
Annual
| Period | Net income | Change |
|---|---|---|
| FY2025 | −$957.0M | — |
| FY2024 | −$638.0M | — |
| FY2023 | $2.7B | — |
| FY2022 | −$2.4B | — |
| FY2021 | $1.3B | 16.67% |
| FY2020 | $1.1B | 9.79% |
| FY2019 | $1.0B | (34.61%) |
| FY2018 | $1.5B | 156.81% |
| FY2017 | $602.0M | (87.88%) |
| FY2016 | $5.0B | 412.91% |
Quarterly
| Period | Net income | Change |
|---|---|---|
| Jun 2026 | $126.0M | — |
| Mar 2026 | −$15.0M | — |
| Dec 2025 | −$1.1B | — |
| Sep 2025 | −$46.0M | — |
| 42 more quarters | Free account |
Against its own ten years
Low −$2.4B
High $5.0B
Ten-year median
$1.0B
Current reading's percentile
18
Net income against peers
| Company | Net income |
|---|---|
| SOLV Solventum Corporation compare | $1.4B |
| COO The Cooper Companies, Inc. compare | $570.3M |
| ALGN Align Technology, Inc. compare | $413.6M |
| ATR AptarGroup, Inc. compare | $362.9M |
| STVN Stevanato Group S.p.A. compare | $219.6M |
| RGEN Repligen Corporation compare | $41.5M |
| BLCO Bausch + Lomb Corporation compare | −$163.0M |
| AVTR Avantor, Inc. compare | −$578.0M |
| BAX Baxter International Inc. | −$1.1B |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on BAX
- Revenue
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement